Union Bancaire Privee UBP SA Grows Position in CME Group Inc. $CME

Posted by Stanley Muller on Jun 28th, 2026

Union Bancaire Privee UBP SA boosted its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 29.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 17,518 shares of the financial services provider’s stock after purchasing an additional 4,032 shares during the period. Union Bancaire Privee UBP SA’s holdings in CME Group were worth $5,174,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of CME Group by 1.7% in the fourth quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock worth $9,802,366,000 after buying an additional 588,509 shares during the period. State Street Corp grew its position in CME Group by 0.4% in the 4th quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock valued at $4,408,747,000 after acquiring an additional 56,725 shares during the last quarter. Norges Bank purchased a new stake in CME Group in the fourth quarter worth $1,523,241,000. Bank of New York Mellon Corp increased its stake in CME Group by 2.8% in the fourth quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock worth $1,344,776,000 after purchasing an additional 134,242 shares during the period. Finally, Ameriprise Financial Inc. lifted its position in shares of CME Group by 2.8% during the third quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock worth $1,300,450,000 after purchasing an additional 130,848 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Argus reissued a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. The Goldman Sachs Group decreased their price objective on shares of CME Group from $275.00 to $267.00 and set a “sell” rating for the company in a report on Thursday, April 23rd. UBS Group restated an “overweight” rating on shares of CME Group in a research note on Monday, June 15th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Finally, JPMorgan Chase & Co. lifted their price target on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research note on Thursday, April 16th. Twelve analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $302.24.

Read Our Latest Report on CME

CME Group Stock Performance

CME stock opened at $221.00 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The business has a 50-day moving average price of $273.13 and a 200 day moving average price of $285.74. The company has a market capitalization of $80.08 billion, a P/E ratio of 18.86, a PEG ratio of 2.47 and a beta of 0.21. CME Group Inc. has a 1-year low of $220.73 and a 1-year high of $329.16.

CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm’s quarterly revenue was up 14.5% on a year-over-year basis. During the same period in the prior year, the business earned $2.80 EPS. As a group, equities research analysts forecast that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s dividend payout ratio is presently 44.37%.

Insider Buying and Selling

In related news, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the transaction, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is currently owned by company insiders.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.